GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nova Leap Health Corp (TSXV:NLH) » Definitions » YoY EBITDA Growth

Nova Leap Health (TSXV:NLH) YoY EBITDA Growth : 184.62% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Nova Leap Health YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Nova Leap Health's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 184.62%.

Nova Leap Health's EBITDA per Share for the three months ended in Mar. 2024 was C$0.01.


Nova Leap Health YoY EBITDA Growth Historical Data

The historical data trend for Nova Leap Health's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Leap Health YoY EBITDA Growth Chart

Nova Leap Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
YoY EBITDA Growth
Get a 7-Day Free Trial 85.19 137.50 633.33 181.82 -88.71

Nova Leap Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -44.44 - -100.00 -35.29 184.62

Nova Leap Health YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Nova Leap Health's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(0.007-0.062)/ | 0.062 |
=-88.71 %

Nova Leap Health's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(0.011--0.013)/ | -0.013 |
=184.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nova Leap Health YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Nova Leap Health's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Nova Leap Health (TSXV:NLH) Business Description

Traded in Other Exchanges
Address
7071 Bayers Road, Suite 3006, Halifax, NS, CAN, B3L 2C2
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of personal home care and support services. The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offering includes meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S operations. The company derives a majority of its revenue from the United States.
Executives
Christopher Donald Dobbin Director, Senior Officer

Nova Leap Health (TSXV:NLH) Headlines

No Headlines